A synthetic investigational peptide studied for its activity at GIP and GLP-1 receptors. It serves as a research tool for investigating receptor pharmacology, metabolic signaling, peptide structure, and related biological pathways.
Not for human consumption
Tirzepatide is a synthetic 39-amino acid peptide with a molecular weight of approximately 4,813.5 Da. Engineered from the glucose-dependent insulinotropic polypeptide (GIP) sequence and modified with a C20 fatty diacid side chain for enhanced stability, tirzepatide represents a structurally advanced peptide designed for prolonged biological activity in experimental models.
Tirzepatide has been extensively characterized in the scientific literature for its interaction with both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R). It serves as a widely recognized research tool for investigating dual receptor pharmacology, peptide engineering, endocrine signaling, receptor binding kinetics, and structure-activity relationships.
You must be at least 21 years old to access The Research Peptides.
All products are sold strictly for in-vitro laboratory research use only.